Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients with Intermediate-risk Acute Myelogenous Leukemia in First Complete Remission-Reference-Cited by-同舟云学术

Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients with Intermediate-risk Acute Myelogenous Leukemia in First Complete Remission

Published:2018-11-26 Issue:6 Volume:25 Page:1737-1748
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Lv Meng,Wang Yu,Chang Ying-Jun,Zhang Xiao-Hui,Xu Lan-Ping,Jiang Qian,Jiang Hao,Lu Jin,Chen Huan,Han Wei,Wang Feng-Rong,Wang Jing-Zhi,Chen Yao,Yan Chen-Hua,Zhang Yuan-Yuan,Sun Yu-Qian,Mo Xiao-Dong,Zhu Hong-Hu,Jia Jin-Song,Zhao Ting,Wang Jing,Liu Kai-Yan,Huang Xiao-Jun

Funder

National Key Research and Development Plan of China

National Natural Science Foundation of China

Science and Technology Project of Guangdong Province of China

Scientific Research Foundation for Capital Medicine Development

Beijing Municipal Science and Technology Commission

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profile of Dr. Xiao-Jun Huang;Science China Life Sciences;2024-07-29

2. Single-cell immune landscape of measurable residual disease in acute myeloid leukemia;Science China Life Sciences;2024-07-19

3. Reduced intensity conditioning regimen of fludarabine, busulfan, ATG based haploidentical stem cell transplantation for older or unfit patients;Annals of Hematology;2024-06-03

4. Comparison of allo-SCT, auto-SCT and chemotherapy for the treatment of patients with low- or intermediate-risk acute myeloid leukemia: a network meta-analysis;Stem Cell Research & Therapy;2024-05-31

5. Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia;Hematology, Transfusion and Cell Therapy;2024-04